Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 246-042-5 | CAS number: 24155-42-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From February 25th to March 22nd, 2016.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- α-(2,4-dichlorophenyl)-1H-imidazole-1-ethanol
- EC Number:
- 246-042-5
- EC Name:
- α-(2,4-dichlorophenyl)-1H-imidazole-1-ethanol
- Cas Number:
- 24155-42-8
- Molecular formula:
- C11H10Cl2N2O
- IUPAC Name:
- 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethan-1-ol
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Husbandry of laboratory animals of the Experimental Medicine Centre at the Medical University in Białystok.
- Females nulliparous and non-pregnant: yes
- Age and weight at study initiation: Two 11-week-old animal weighing 205.0 and 219.0 g (dose of 300 and 2000 mg/kg bw respectively) were used in the preliminary experiment, and four 12-week-old animals, whose average body weight was 213.0 g (dose of 2000 mg/kg b.w.) were used in the main experiment.
- Fasting period before study: 19 hours
- Housing: The animals were kept in plastic cages covered with wire bar lids. The dimensions of the cages were 58 x 37 x 21 cm. In the preliminary experiment, the animals were caged individually. In the main experiment, there were four animals in one cage. UV-sterilized wood shavings were used as bedding. The environment of the animals was enriched by placing wooden blocks and nesting materials for laboratory animals in the cages.
- Diet (e.g. ad libitum): Murigran standard granulated laboratory fodder ad libitum.
- Water (e.g. ad libitum): Tap water ad libitum.
- Acclimation period: 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-23ºC
- Humidity (%): 28-55%
- Air changes (per hr): 16 times/hour
- Photoperiod (hrs dark / hrs light): 12 hours light/12 hours dark
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 60mg/mL (300 mg/kg bw) and 400 mg/mL (2000 mg/kg bw)
- Amount of vehicle (if gavage): 1 mL
- Justification for choice of vehicle: Low water solubility.
- Other: The suspensions were prepared on the administration day (shortly before the administration).
MAXIMUM DOSE VOLUME APPLIED: 0.5 mL/100 g bw - Doses:
- Preliminary test: 300 mg/kg bw and 2000 mg/kg bw.
Main test: 2000 mg/kg bw. - No. of animals per sex per dose:
- One female was used for the preliminary experiment at 300 mg/kg bw. One female was then used at 2000 mg/kg bw.
Based on the results, four additional females were used at 2000 mg/kg bw in the main experiment. - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: General condition of the animals at least once a day, clinical detailed observations on day 0: 10, 30 and 60 minutes after the administration and then at hourly intervals up to 5th hour after the administration of the test item. Thereafter once a day from the day 1 to the day 14. Weight was determined on day 0 (directly before administration), 7 and 14 before euthanasia.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross examinations.
Results and discussion
- Preliminary study:
- Since no data were available, the preliminary experiment started with the administration of the test item at a dose of 300 mg/kg b.w. to one animal.
Since no evident toxicity was observed in dose 300 mg/kg bw, the test item at a single dose of 2000 mg/k g b.w. was administered to the second animal.
On the grounds of the preliminary experiment results, the dose of 2000 mg/kg bw was selected to be used in the main experiment and it was applied to four further rats.
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- One animal (1/5) died on the third day after administration of the test item at a dose of 2000 mg/kg bw.
- Clinical signs:
- other: Following administration of the test item at a single dose of 2000 mg/kg bw, the following changes were observed on the day of administration of the test item: rounded back, slightly decreased locomotor activity, bristled coat. In two animals distinct dec
- Gross pathology:
- In the preliminary experiments gross examinations did not reveal any pathological changes in the examined animals (one animal received 300 mg/kg bw and other 2000 mg/kg bw). In the main experiment (four animals 2000 mg/kg bw) the female no. 4, died during the experiment. The macroscopic examination showed porphyrin deposition around the eyes. No pathological changes were noticed in the remaining animals
Any other information on results incl. tables
Table 1. Acute oral toxicity results in rats.
|
Preliminary experiment |
Main experiment |
|
Test item (mg/kg bw) |
300 |
2000 |
2000 |
Mortality |
0/1 |
0/1 |
1/4 |
Clinical signs |
No |
Rounded back; slight, and then distinct decreases of locomotor activity, bristled coat. |
In all animals: Rounded back, slight decreases of locomotor activity, bristled coat. |
In two animals (no. 4, 5): distinct decreases of locomotor activity. |
|||
In one animal (no.4): wavering gait, animal lying on one side, animal could be easy to catch, no reaction to sound stimuli, porphyrin deposition around the eyes. |
Table 2. Body weights of the animals, overall list
Dose (mg/kg b.w.) |
Animal number |
Day of the experiment |
Body weight gain (g) 0 to14 |
||
0 |
7 |
14 |
|||
300 |
1* |
205 |
223 |
237 |
32 |
2000 |
1* |
219 |
238 |
248 |
29 |
2 |
212 |
229 |
237 |
25 |
|
3 |
210 |
234 |
235 |
25 |
|
4 |
218 |
195** |
- |
- |
|
5 |
212 |
227 |
247 |
35 |
* Females from the preliminary experiment
** Animal body weight after death
Table 3. Clinical signs, overall list.
Dose (mg/kg bw) |
Day after Administration |
No. of living Animals |
Animal number |
||||
1* |
2 |
3 |
4 |
5 |
|||
300 |
0 |
1 |
NC |
|
|
|
|
1 |
1 |
NC |
|||||
2 |
1 |
NC |
|||||
3 |
1 |
NC |
|||||
4 |
1 |
NC |
|||||
5 |
1 |
NC |
|||||
6 |
1 |
NC |
|||||
7 |
1 |
NC |
|||||
8 |
1 |
NC |
|||||
9 |
1 |
NC |
|||||
10 |
1 |
NC |
|||||
11 |
1 |
NC |
|||||
12 |
1 |
NC |
|||||
13 |
1 |
NC |
|||||
14 |
1 |
NC |
|||||
2000 |
0 |
5 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
1 |
5 |
SIGNS |
NC |
NC |
SIGNS |
NC |
|
2 |
5 |
SIGNS |
NC |
NC |
SIGNS |
NC |
|
3 |
4 |
SIGNS |
NC |
NC |
D |
NC |
|
4 |
4 |
SIGNS |
NC |
NC |
- |
NC |
|
5 |
4 |
SIGNS |
NC |
NC |
- |
NC |
|
6 |
4 |
NC |
NC |
NC |
- |
NC |
|
7 |
4 |
NC |
NC |
NC |
- |
NC |
|
8 |
4 |
NC |
NC |
NC |
- |
NC |
|
9 |
4 |
NC |
NC |
NC |
- |
NC |
|
10 |
4 |
NC |
NC |
NC |
- |
NC |
|
11 |
4 |
NC |
NC |
NC |
- |
NC |
|
12 |
4 |
NC |
NC |
NC |
- |
NC |
|
13 |
4 |
NC |
NC |
NC |
- |
NC |
|
14 |
4 |
NC |
NC |
NC |
- |
NC |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- EU criteria
- Conclusions:
- The oral LD50 for the test substance in female rats was superior to 2000 mg/kg bw.
- Executive summary:
The potential acute toxicity of the test item was studied on female Wistar rats, according to OECD TG 420, under GLP conditions. Since no data on acute toxicity was available, the first dose used in the preliminary test was 300 mg/kg bw test item in corn oil. As no evident toxicity was observed at this dose, a second animal was administered 2000 mg/kg bw test item. Based on the preliminary test results, the main experiment was performed by administering a single dose of 2000 mg/kg bw test item to four animals. Following administration, changes in body posture, locomotor activity, and bristled coat were observed in all animals. One animal died on the third day after the administration of the test item, the remaining animals survived the experiment and showed no pathological changes upon necrosis. Based on the results, the oral LD50 was found to be > 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.